mumbaistatin: inhibits glucose-6-phosphate translocase; isolated from Streptomyces sp.; structure in first source
ID Source | ID |
---|---|
PubMed CID | 9850474 |
CHEMBL ID | 238371 |
SCHEMBL ID | 13238512 |
MeSH ID | M0393711 |
Synonym |
---|
CHEMBL238371 |
mumbaistatin |
SCHEMBL13238512 |
bdbm50476959 |
1-[2-(5-carboxy-4-hydroxypentanoyl)-6-hydroxybenzoyl]-3,8-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid |
mumbaistatin (1) |
Q44207859 |
DTXSID701037340 |
252961-22-1 |
Mumbaistatin is an anthraquinone derivative, whose open-chain diketo form acts as a specific and powerful inhibitor of glucose-6-phosphate translocase.
Excerpt | Reference | Relevance |
---|---|---|
"Mumbaistatin is an anthraquinone derivative, whose open-chain diketo form acts as a specific and powerful inhibitor of glucose-6-phosphate translocase: IC50=5 nM." | ( The chemical structure of mumbaistatin, a novel glucose-6-phosphate translocase inhibitor produced by Streptomyces sp. DSM 11641. Hammann, P; Kurz, M; Paulus, EF; Schummer, D; VĂ©rtesy, L, 2001) | 1.33 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) | IC50 (µMol) | 0.0050 | 0.0030 | 0.0040 | 0.0050 | AID299949 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
glucose metabolic process | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
gluconeogenesis | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
glucose-6-phosphate transport | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
phosphate ion transmembrane transport | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
protein binding | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
glucose-6-phosphate transmembrane transporter activity | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
glucose 6-phosphate:phosphate antiporter activity | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
endoplasmic reticulum | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
endoplasmic reticulum membrane | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
membrane | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
endoplasmic reticulum membrane | Glucose-6-phosphate exchanger SLC37A4 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID299949 | Inhibition of glucose 6 phosphate translocase 1 | 2007 | Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15 | Structure-activity relationships of semisynthetic mumbaistatin analogs. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.33) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |